ATE312846T1 - Monoklonale antikörper gegen hepatitis b virus - Google Patents

Monoklonale antikörper gegen hepatitis b virus

Info

Publication number
ATE312846T1
ATE312846T1 AT01976422T AT01976422T ATE312846T1 AT E312846 T1 ATE312846 T1 AT E312846T1 AT 01976422 T AT01976422 T AT 01976422T AT 01976422 T AT01976422 T AT 01976422T AT E312846 T1 ATE312846 T1 AT E312846T1
Authority
AT
Austria
Prior art keywords
virus
monoclonal antibodies
antibodies against
hbsag antigen
against hepatitis
Prior art date
Application number
AT01976422T
Other languages
English (en)
Inventor
Mylene Lesenechal
Nicole Battail-Poirot
Laurence Becquart
Original Assignee
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Sa filed Critical Biomerieux Sa
Application granted granted Critical
Publication of ATE312846T1 publication Critical patent/ATE312846T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01976422T 2000-10-20 2001-10-12 Monoklonale antikörper gegen hepatitis b virus ATE312846T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0013454A FR2815634B1 (fr) 2000-10-20 2000-10-20 Anticorps monoclonaux diriges contre des virus de l'hepatite b
PCT/FR2001/003169 WO2002034789A1 (fr) 2000-10-20 2001-10-12 Anticorps monoclonaux diriges contre des virus de l'hepatite b

Publications (1)

Publication Number Publication Date
ATE312846T1 true ATE312846T1 (de) 2005-12-15

Family

ID=8855552

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976422T ATE312846T1 (de) 2000-10-20 2001-10-12 Monoklonale antikörper gegen hepatitis b virus

Country Status (9)

Country Link
US (1) US7785586B2 (de)
EP (1) EP1326895B8 (de)
JP (1) JP4293788B2 (de)
AT (1) ATE312846T1 (de)
AU (1) AU2001295700A1 (de)
DE (1) DE60115938T2 (de)
ES (1) ES2252301T3 (de)
FR (1) FR2815634B1 (de)
WO (1) WO2002034789A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
CN101426936B (zh) * 2004-06-07 2013-03-20 诺华疫苗和诊断公司 乙肝表面抗原的兔单克隆抗体及其应用方法
CA2594922A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
JP4948783B2 (ja) * 2005-05-18 2012-06-06 シスメックス株式会社 抗ＨＢｓモノクローナル抗体
AU2013287516B2 (en) * 2012-07-10 2016-07-07 Green Cross Corporation An antibody composition for prevention or treatment of mutant hepatitis B virus infection
CN105263522B (zh) * 2013-05-31 2019-03-22 赛特瑞恩股份有限公司 可中和乙肝病毒的结合分子
US9714284B2 (en) * 2013-07-16 2017-07-25 National Health Research Institutes Antibodies and method for determining deletions in HBV pre-S2 region
CN104845938B (zh) * 2015-04-17 2018-07-03 北京科兴中维生物技术有限公司 乙型肝炎病毒表面抗原单克隆抗体及其应用
CN111234013B (zh) * 2018-11-29 2022-01-11 清华大学 乙肝病毒的中和抗体b430及其应用
CN116496389A (zh) * 2022-01-25 2023-07-28 厦门大学 用于治疗hbv感染及相关疾病的表位肽及抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204095A (en) * 1980-04-09 1993-04-20 National Research Development Corporation Monoclonal antibodies against hepatitis B virus
GB9007024D0 (en) * 1990-03-29 1990-05-30 Imperial College Novel vaccine
US6030616A (en) * 1993-03-24 2000-02-29 Imperial College Of Science, Technology & Medicine Hepatitis B escape mutant specific binding molecules
GB9325772D0 (en) * 1993-12-16 1994-02-16 Smithkline Beecham Biolog Novel compounds
GB9608626D0 (en) * 1996-04-25 1996-07-03 Univ College Of London Hepatitis b monoclonal antibodies
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization

Also Published As

Publication number Publication date
AU2001295700A1 (en) 2002-05-06
DE60115938T2 (de) 2006-07-27
JP4293788B2 (ja) 2009-07-08
US7785586B2 (en) 2010-08-31
DE60115938D1 (de) 2006-01-19
EP1326895B1 (de) 2005-12-14
FR2815634B1 (fr) 2003-10-31
WO2002034789A1 (fr) 2002-05-02
FR2815634A1 (fr) 2002-04-26
JP2004516824A (ja) 2004-06-10
EP1326895A1 (de) 2003-07-16
ES2252301T3 (es) 2006-05-16
EP1326895B8 (de) 2006-06-21
US20040219154A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
ATE125821T1 (de) Vakzin gegen hepatitis b.
DK1135498T3 (da) Antistofvarianter med höjere bindingsaffinitet end forældreantistoffer
JP2002533123A5 (de)
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
PL1639011T3 (pl) Pegilowane przeciwciała jednodomenowe (dAb)
EA200100619A1 (ru) Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов
IL221708A0 (en) Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response
HUP0303134A3 (en) Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv
FI935808A0 (fi) Hepatit-C-virus (HCV) polypeptider
UY28641A1 (es) Anticuerpos
DE60234085D1 (de) Rekombinantes super-verbindungs-interferon zur verwendung als hepatitis b oberflächenatigen und e-antigen-inhibitor
ATE312846T1 (de) Monoklonale antikörper gegen hepatitis b virus
MX9603182A (es) Vacuna de hepatitis b.
NO20051715L (no) HCV assay
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
DK1002092T3 (da) Mimotoper af hypervariabel region 1 af E2-glycoproteinet fra HCV og anvendelser deraf
IS6143A (is) Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni
NO20022147L (no) Mimetiske peptider for epitope av apolipoprotein B-100, konkatamer og modifiserte peptider derav, og vaksinesammensetningsom omfatter det samme
ATE552264T1 (de) Neue oberflächenprotein- (hbsag-) variante des hepatitis b virus
DE755943T1 (de) Durch Antikörper gegen das C33-Antigen des Hepatitis C-Virus erkennbares Peptid
BRPI0204599B8 (pt) kit para a detecção simultânea de anticorpo para hcv e antígeno de hcv
WO2000042194A3 (en) Mutant hepatitis b surface antigen and testing
GR3036125T3 (en) Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
FR2818648B1 (fr) Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties